An FDA advisory committee on Wednesday unanimously voted against recommending approval of the PARP inhibitor talazoparib ...

A class of older drugs used to treat type 2 diabetes may also help slow the progression of prostate cancer, a small study ...

Experts say the decision of whether to screen men for prostate cancer past the age of 70 should be made on an individual ...

When caught early, prostate cancer is highly survivable, but it is also the second-leading cause of cancer death in men.

Pfizer Inc. failed to convince advisers to the US Food and Drug Administration to support a dramatic expansion in the use of ...

Prostate cancer is getting easier to identify and treat. New drugs are easier to take, and work even better than their ...

While prognoses for prostate cancer patients were once measured in months, experts say that advances in treatment and ...

It is not unusual for a man of Biden’s age to skip prostate cancer screening, for a variety of reasons.

Biden’s cancer has spread to the bone, his office said. That makes it more serious than localized or early-stage prostate ...